chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient got the 1st dose of pfizer and was fine at the time of administration.  However, as she sat down on the chair for observation, that was when she fainted and fell off but someone was there to catch her.  After a minute, she regained her consciousness back.  We took her BLOOD PRESSURE and it was normal.  Ambulance came and took her to hospital.  Yesterday, her sister came to pharmacy and asked if it was normal for her to keep having runny nose.  We told her she might feel like flu-like symptom but to be safe, it's better she goes  to see her primary doctor/urgent care.
rec'vd flu shot, came home, cooked stuffed cabbage. 1.5 hr later, chest began hurting, breathing rapid. Went to lay down, got up and vomit with diareah. Was too sick to get up, stayed down on the floor, they called 911, stayed in the hospital for 3 days, was tested for covid-neg results. Pt was kept due to fever that was steady.
Developed full body rash 45 mins after injection, stomach pain,, "throat hurt".
I was sick for a day or two; 24-48 hours of feeling a little uncomfortable; headache; general fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I was sick for a day or two), DISCOMFORT (24-48 hours of feeling a little uncomfortable), HEADACHE (headache) and FATIGUE (general fatigue) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 028L20A) for COVID-19 vaccination.     Concomitant products included ACYCLOVIR [ACICLOVIR], ACETYLSALICYLIC ACID (BABY ASPIRIN) and HYDRALAZINE for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (I was sick for a day or two), DISCOMFORT (24-48 hours of feeling a little uncomfortable), HEADACHE (headache) and FATIGUE (general fatigue). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (I was sick for a day or two), DISCOMFORT (24-48 hours of feeling a little uncomfortable), HEADACHE (headache) and FATIGUE (general fatigue) outcome was unknown.            This case was linked to MOD-2021-345790 (Patient Link).
She had a huge welt on her arm.; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (She had a huge welt on her arm.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 018B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (She had a huge welt on her arm.). At the time of the report, URTICARIA (She had a huge welt on her arm.) had resolved.            No Concomitant Products were reported. Patient condition include Special needs Nonverbal. No Treatment information was reported.   This case was linked to MOD-2022-560539 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2022: Non-significant follow up appended
Patients right arm (upper deltoid area) was swollen and hard, also developed redness, hot to touch on 8/12/15. Patient seen on 8/14/15 symptoms subsided. Dx local reaction.
I practice herbal medicines and I have not had things injected in me since I was a child however, I felt symptoms right away from shortness of breath my right jaw line, felt as if I was having a stroking & I am only 30 no underline conditions or high blood pressure or diabetes . I felt weak which I know is common my symptoms spanded for 3 weeks I felt my right ear experience ringing. I also experienced the vaccine seeping to the right side back of my neck was a throbbing pain, than as the days went I felt the right side of my eye feeling droopy as if the vaccine gave me post Stroke symptoms, I had a rash start to form under my left arm that turned raw that has never happen, it was rash and I do not have eczema. I also felt serve head aches and also a rash around my lips and the crack line of my lips as white marks, and it was not from any sexual transmitted diseases because I practice celibacy's, I have a red rash in my lip closer to my teeth line
This spontaneous report was received from a 71 year old female patient who was reporting on herself. The patient's medical history was not provided. Her concurrent conditions included high blood pressure. On 04-DEC-2015, the patient was vaccinated with a dose of ZOSTAVAX (1 shot, subcutaneously; dose, lot # and expiration date were not reported). Concomitant therapies included lisinopril (manufacturer unknown) and CRESTOR. On 05-DEC-2015, the patient experienced giant itchy hive on arm with redness and swelling. It was provided that the symptoms were localized at the site of ZOSTAVAX injection. The patient sought medical attention via a contact with an unspecified pharmacy. No treatment was given for the adverse events and none lab diagnostics studies were performed. The outcome of the adverse events was reported as not recovered. The relatedness between the adverse events and ZOSTAVAX was not reported. Additional information has been requested.
This spontaneous report as received from a physician refers to a patient of unknown age. On an unknown date the patient was vaccinated with VAQTA (dose, frequency and route not specified). Concomitant medications were not reported. The physician reported that on an unknown date the patient has not had the recommended booster dose of VAQTA 6 to 18 months after receiving the first dose. The physician inquired if it had been years since the primary dose, would the recommendation be, to simply give the booster dose anyway or to start all over again. The outcome of not taking the booster dose was unknown. Additional information has been requested.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021 at 5:19 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Nov-2021 at 5:19 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. The vial undergone temperature excursions for 1 month. The vial was in frozen state at the time of the excursion (Vials in question stored in a super cold Freezer) and minimum reached temperatures was negative 82 degrees Fahrenheit. The patient was given dose from vial that was stored in an ultracold freezer which was colder than it should have been. The vial moved from freezer to refrigerator on 19-Nov-2021, it was a day when the Moderna Covid-19 vials went from the super cold freezer to the refrigerator. The vials were returned to the freezer/refrigerator or maintained at room temperature.  The reporter stated that total 70 vials were still in the ultra-cold freezer and 8 vials were in the refrigerator. No vaccine state changes were noticed. The vaccine was never refrozen. None of the vials were punctured. No Previous temperature excursions was reported. No treatment medications were provided.   This case was linked to MOD-2021-402935 (Patient Link).
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 06-MAR-2019, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number R021055 with expiration date in 01-APR-2020) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001848: US-009507513-1907USA001849: US-009507513-1906USA011434: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA001847: US-009507513-1907USA000952: US-009507513-1907USA000989: US-009507513-1907USA000962: US-009507513-1907USA000988: US-009507513-1907USA000963: US-009507513-1907USA000953: US-009507513-1907USA000959: US-009507513-1907USA000968: US-009507513-1907USA000967: US-009507513-1907USA000964: US-009507513-1907USA000966: US-009507513-1907USA000954: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000965:
Started coughing that night. Turned into muscle weakness that is constant - not getting better. Occasionally has muscle spasms.
1) After midnight, I began to get what felt like the shivers, but they were unlike anything I had ever seen or experienced, as I could not stop shaking, feeling like I had to try to get warm.  I had a heat pack under my back, and no temperature, but for 25 minutes, kept shaking. 2) At 10am in the morning, I began hallucinating, which has never happened to me before, and I only recognize because when my Dad was dying of prostate cancer, they had him on morphine and he began to see things.  It was a very specific hallucination, of being in a specific from in front of a specific computer talking to a person.  I feel quite reluctant to share this.  This lasted for somewhere between 30 and 45 minutes. 3) I've vomited once, and had diarrhea, drinking lots of water, and only using Tylenol.  I did not take the Tylenol until after I stopped shivering.
Fever 102, body aches, rash, vision blurriness after pna, flu and hep a vaccines.
I called EMS due to sudden numbness in my right-arm and on my right-side above the waist. I was concerned about the possibility of a stroke, but EMS ruled-out that as symptoms were not consistent with a stroke. I have had symptoms up until 10-25-2022. The duration and frequency of symptoms seem to be decreasing since the vaccination. They were the most severe in both duration and frequency for the first 7-10 days after the vaccination.
Vertigo onset 12 hours after administration, light headed feeling persists 4 weeks later,  treated with light dose of meclizine
pt recvd vax;devel tenderness, swelling & erythema at inject site; fever & HA w/in 24 hrs p/ vax; sxs began to subside 2 days later
Red, puffy and sore. Rx - BACTRIM DS, BACTROBAN and cold compress.
pt recv vax 24APR97 & exp ankle edema & arthritis-like pain in the lower extremities;lab eval on 16MAY97 revealed fluorescent antinuclear antibody (FANA) positive @ 1 to 160;
This spontaneous case reported by a consumer, describes the occurrence of injection site pain and injection site erythema (2 inch red circle around injection site) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 003C21A) for COVID-19 immunization. No medical history reported. On Apr 29, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 30, 2021, patient experienced injection site pain and injection site erythema (2 inch red circle around injection site). At the time of the report, injection site pain and injection site erythema (2 inch red circle around injection site) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication, treatment information or causality assessments provided.
This is a spontaneous report from a contactable nurse received via a sales representative. A female patient of an unspecified age and ethnicity received the first dose of TRUMENBA, intramuscular at 0.5 ml single and the first dose of MENVEO, intramuscular at 1 DF single, both on the same unspecified date. The patient medical history and concomitant medications were not reported. A few hours after vaccines were given, the patient experienced dizziness/ lightheadedness and passed out. Patient went to the Emergency Department. Date of visit to Emergency Department unknown, duration of visit unknown. Treatment unknown by caller. He stated she had blood work done and the blood work was fine. Patient's outcome reported as recovered completely.
I started having ringing in my left ear. I thought it was a really bad sinus infection. The ringing did not go away. We were in the middle of Covid-19 and I was hoping it would go away. Before I got the booster I thought I needed to get this checked out. I went to my PCP and she encourage me to get the booster. I did get it on 12/08/2021. The situation did not change. She recommended me to see an ENT. I saw him last Monday and he did a hearing test and he said I have Tinnitus. He does not think it was because of the vaccine. I still having the ringing. It is constant.
Pt recvd 2nd immun & w/in a couple of hrs devel a fever to 102, irritability & then hives which resolved w/DPH;
Patient received only a partial dose; A Spontaneous report was received from a healthcare professional concerning a female healthcare worker in her '50s' who was participating in the mRNA-1273 Emergency Use Program and the patient received only a partial dose.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 27 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot # 028L20A) for prophylaxis of COVID-19 infection. The patient received only a partial dose and does not have any special condition. No treatment information was provided.   Action taken with the second dose of mRNA-1273 in response to the event was not reported.   The event, patient received only a partial dose was considered resolved on 27 JAN 2021.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273.  There were no reported adverse events associated with this case.
Patient dizzy, diaphoretic, light-headed immediately after vaccination; fever and chills at 11:00 PM on 27th - vomiting x 1 during night, unable to eat until evening on 28th - feeling fine on the 29th.
Immediately after, the usual - nausea, arm pain, faintness. The next day - chills/fever, fatigue, nausea. Persisting for nearly 3 weeks to present - enlarged spleen presenting with spleen pain (something I haven't experienced since December with covid and in earlier 2020 with mono), fatigue, back pain, indigestion, nausea, right arm soreness at site of injection, joint pain
Expired ANTHRAX administered Lot FAV231, exp date 4Oct10. Give 15 Oct 10. No adverse reaction noted.
Patient expierenced dizziness, sweating, fatigue after flu vaccine. She stayed at the pharmacy for 30 minutes and drank water. I consulted with nurse at the patients pediatrician who advised giving the patient something to eat/drink with sugar due to possible vasovagal syncope. The patients mom was advised to call the pediatrician if symptoms worsened or persisted once she returned home. I called the patients mom 2 hours after vaccination and she said she was doing fine.
At around 5pm the day of vaccination, a rash developed on my whole neck. It had hives, and it was very itchy, red, with a burning sensation. this persisted through the night. the itchiness and burning the next night was gone, but the rash remained. it is sensitive when touched, and it does start burning and itching again. it has some blistering, but has remained the same (minus the consistent itching and burning) since it started the day of the vaccine. i did test positive for COVID on 12/26/2021, but symptoms started 12/25/2021. rashes were not a symptom while actively contagious with the virus.
This is a spontaneous report from a contactable consumer reported for herself. A 58-year-old female patient received PREVNAR 13 on 05Dec2017 via an unknown route of administration in the right arm at single dose for Immunisation. Relevant medical history included spleen removed, in 1998 or 1999. The patient a history of being immunocompromised as chronic condition. Concomitant Products included regular vitamins. In the past after the spleen removed the patient had received PNEUMOVAX. On 05Dec2017 the patient experienced low grade fever, then a high grade fever 102-103 Fahrenheit, injection site was red, itchy, tender, painful, and hard, she had muscle aches, joint aches, headache, on 11Dec2017 lack of appetite, nausea, throwing up, and on unknown date feeling sick like a dog, Fatigue, Weak and pressure inside her head. Doctor had given her an antibiotic because concerned injection site may be injected. She is taking BENADRYL for the injection site reaction like itchiness. She is taking TYLENOL for fever and Ibuprofen for the aches: muscle and joint aches. The outcome of the events was reported as recovering except for pyrexia with outcome of recovered, decreased appetite, nausea, malaise, fatigue, Asthenia with outcome of not recovered and vomiting and Head discomfort with outcome of unknown. She went to urgent care and they checked her for the flu and it came back negative. No virus. Negative for any type of viral infection. Information on the batch number has been requested.
Fever 101.2 beginning day after vaccines and lasting to following day. Headache, muscle and joint aches, exhaustion the night of vaccines. Chicken pox like bumps and swollen gland appeared under and around arm that received shots two days after shots. Chills and shaking from first to third day.
Narrative:  PATIENT WAS VACCINATED IN TIMELY MANNER 3/19 AND 4/10 RESPECTIVELY WITH PFIZER MRNA VACCINE. PATIENT PRESENTED TO ED 11/4 WITH DKA AND WAS FOUND TO BE COVID POSITIVE. HE WAS ADMITTED FOR DKA LIKELY COMPLICATED BY COVID, BUT OTHER THAN TX WITH CAS/IMDE MAB, PT REQUIRED NO 02 OR OTHER COVID TREATMENT.  PATIENT WAS TREATED, RECOVERED. AND DISCHARGED TO HOME.
PT WAS BROUGHT INTO CLINIC HERE ON 12/3/2010.  VISUALIZED SEVERAL AREAS OF RED SKIN, SOME OPEN SORES, SOME DRY SCABS, SOME PUSSED AREAS.  ITCHING A LOT PER PATIENT.  NOTED BOTH INNER WRISTS, BOTH INNER ELBOWS, CHEST, NECK, EAR (L) VERY RED WITH PUSSED SPOT.  ABDOMEN HAD NUMEROUS RED SPOTS.  STATES NO FEVERS, NO BLISTER AT INJECTION SITE.  NO PROBLEMS BREATHING-JUST NOW TODAY HURT TO BREATHE DEEP.  REFERRED PARENT TO TAKE CHILD TO DR TODAY.  WILL CALL AND REPORT.  THESE ITCHING, SPLOTCHY AREAS STARTED 1 WEEK AFTER SHOTS.
28 year old male with history of pericarditis in 2018 with recurrence that occurred approximately 3 weeks after 2nd dose of Pfizer vaccine.  No elevated troponins, but did have EKG changes; no comparison from previous studies.
Information has been received from a female consumer who on 16-JUN-2010 was vaccinated with a dose of ZOSTAVAX (Merck). On 16-JUN-2010, after getting ZOSTAVAX (Merck), the patient experienced shingles. At this time of reporting, the patient's shingles persisted. No further information is available.
Patient started to feel itchy, had "burning" sensation shortly after injection. Patient was given initial dose of Benadryl and walked to the on-site urgent care clinic. In urgent care following IVs were administered: Pepcid, Benadryl, Solumedrol. Patient was monitored for about 2 hours. Symptoms mostly resolved in that time, still had some residual itching but felt comfortable for discharge. Discharged with outpatient medications of prednisone, famotidine, and Benadryl.
Received MMR on 7-15-08.  7-25-08 patient had generalized seizure.  Had 102 temperature.  Taken to ER.  Normal labs.  Also developed vomiting x 24 hours, diarrhea several days.  No prolonged Rx.  No residual symptoms.
expired Twinrix administered to a patient.; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 66-year-old female patient who received HAB (Twinrix) (batch number DK23D, expiry date 8th February 2022) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 10th March 2022, the patient received Twinrix and Twinrix Pre-Filled Syringe Device. On 10th March 2022, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The registered nurse reported the use of Twinrix dose to a patient, as the vaccine was already expired on 8th February 2022, which led to expired vaccine used. The reporter consented to follow up.